These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33253326)

  • 21. Network-based modeling of drug effects on disease module in systemic sclerosis.
    Kim KJ; Moon SJ; Park KS; Tagkopoulos I
    Sci Rep; 2020 Aug; 10(1):13393. PubMed ID: 32770109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.
    Bhattacharyya S; Wang W; Qin W; Cheng K; Coulup S; Chavez S; Jiang S; Raparia K; De Almeida LMV; Stehlik C; Tamaki Z; Yin H; Varga J
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA-Sequencing Analysis in Patients With Systemic Sclerosis.
    Roberson EDO; Carns M; Cao L; Aren K; Goldberg IA; Morales-Heil DJ; Korman BD; Atkinson JP; Varga J
    Arthritis Rheumatol; 2023 Jan; 75(1):108-119. PubMed ID: 35762854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.
    Bagnato GL; Roberts WN; Fiorenza A; Arcuri C; Certo R; Trimarchi F; Ruggeri RM; Bagnato GF
    Endocrine; 2016 Feb; 51(2):291-7. PubMed ID: 25994300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis.
    Renaud L; da Silveira WA; Takamura N; Hardiman G; Feghali-Bostwick C
    Front Immunol; 2020; 11():383. PubMed ID: 32210969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of prognosis in patients with systemic sclerosis based on a machine-learning model.
    Zheng Y; Jin W; Zheng Z; Zhang K; Jia J; Lei C; Wang W; Zhu P
    Clin Rheumatol; 2024 Aug; 43(8):2573-2584. PubMed ID: 38937388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
    Beretta L; Barturen G; Vigone B; Bellocchi C; Hunzelmann N; De Langhe E; Cervera R; Gerosa M; Kovács L; Ortega Castro R; Almeida I; Cornec D; Chizzolini C; Pers JO; Makowska Z; Lesche R; Kerick M; Alarcón-Riquelme ME; Martin J; ;
    Ann Rheum Dis; 2020 Sep; 79(9):1218-1226. PubMed ID: 32561607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in macrophage transcriptome associate with systemic sclerosis and mediate
    Moreno-Moral A; Bagnati M; Koturan S; Ko JH; Fonseca C; Harmston N; Game L; Martin J; Ong V; Abraham DJ; Denton CP; Behmoaras J; Petretto E
    Ann Rheum Dis; 2018 Apr; 77(4):596-601. PubMed ID: 29348297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.
    Sargent JL; Li Z; Aliprantis AO; Greenblatt M; Lemaire R; Wu MH; Wei J; Taroni J; Harris A; Long KB; Burgwin C; Artlett CM; Blankenhorn EP; Lafyatis R; Varga J; Clark SH; Whitfield ML
    Arthritis Rheumatol; 2016 Aug; 68(8):2003-15. PubMed ID: 26945694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
    Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
    Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets.
    Franks JM; Martyanov V; Cai G; Wang Y; Li Z; Wood TA; Whitfield ML
    Arthritis Rheumatol; 2019 Oct; 71(10):1701-1710. PubMed ID: 30920766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry.
    Renaud L; Waldrep KM; da Silveira WA; Pilewski JM; Feghali-Bostwick CA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma.
    Gur C; Wang SY; Sheban F; Zada M; Li B; Kharouf F; Peleg H; Aamar S; Yalin A; Kirschenbaum D; Braun-Moscovici Y; Jaitin DA; Meir-Salame T; Hagai E; Kragesteen BK; Avni B; Grisariu S; Bornstein C; Shlomi-Loubaton S; David E; Shreberk-Hassidim R; Molho-Pessach V; Amar D; Tzur T; Kuint R; Gross M; Barboy O; Moshe A; Fellus-Alyagor L; Hirsch D; Addadi Y; Erenfeld S; Biton M; Tzemach T; Elazary A; Naparstek Y; Tzemach R; Weiner A; Giladi A; Balbir-Gurman A; Amit I
    Cell; 2022 Apr; 185(8):1373-1388.e20. PubMed ID: 35381199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.
    Servaas NH; Hiddingh S; Chouri E; Wichers CGK; Affandi AJ; Ottria A; Bekker CPJ; Cossu M; Silva-Cardoso SC; van der Kroef M; Hinrichs AC; Carvalheiro T; Vazirpanah N; Beretta L; Rossato M; Bonte-Mineur F; Radstake TRDJ; Kuiper JJW; Boes M; Pandit A
    Arthritis Rheumatol; 2023 Feb; 75(2):279-292. PubMed ID: 36482877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel classification for global gene signature model for predicting severity of systemic sclerosis.
    Johnson ZI; Jones JD; Mukherjee A; Ren D; Feghali-Bostwick C; Conley YP; Yates CC
    PLoS One; 2018; 13(6):e0199314. PubMed ID: 29924864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.